MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Assets | ₹27,755 Cr | ₹27,652 Cr | ₹11,883 Cr | ₹9,686 Cr | ₹9,108 Cr |
What is the latest Total Assets ratio of MANKIND PHARMA ?
| Year | Total Assets |
|---|---|
| Mar2026 | ₹27,755 Cr |
| Mar2025 | ₹27,652 Cr |
| Mar2024 | ₹11,883 Cr |
| Mar2023 | ₹9,686 Cr |
| Mar2022 | ₹9,108 Cr |
How is Total Assets of MANKIND PHARMA Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹27,755 Cr | 0.37 | |
| Mar2025 | ₹27,652 Cr | 132.70 | |
| Mar2024 | ₹11,883 Cr | 22.68 | |
| Mar2023 | ₹9,686 Cr | 6.34 | |
| Mar2022 | ₹9,108 Cr | - | |
Compare Total Assets of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹106,461.1 Cr | 1.2% | 6.6% | -5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.2% |
6.6% |
-5% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses